Finding 975456 (2023-014)

Material Weakness
Requirement
C
Questioned Costs
-
Year
2023
Accepted
2024-05-30
Audit: 307647
Organization: Wheeling Jesuit University INC (WV)
Auditor: Bdo USA PC

AI Summary

  • Core Issue: The University drew more federal funds than it spent, leading to noncompliance with cash management rules.
  • Impacted Requirements: Advance payments must match actual cash needs and not be mixed with non-federal funds.
  • Recommended Follow-Up: Improve internal controls to ensure accurate documentation and prevent fund commingling.

Finding Text

Finding 2023-014 – C. Cash Management Information on Federal Program(s) – Research and Development Cluster (ALN 43.009, ALN 93.859) Criteria or Specific Requirement - 2 CFR §200.305(b)(1) indicates that advance payments to a non-Federal entity must be limited to the minimum amounts needed and be timed to be in accordance with actual, immediate cash requirements of the non-Federal entity in carrying out the purpose of the approved program or project. The timing and amount of advance payments must be as close as administratively feasible to the actual disbursements by the non-Federal entity for direct program or project costs and the proportionate share of any allowable indirect costs. Condition – The University was unable to reconcile amounts drawn with amounts expended; the total amount drawn exceeded the amount expended for the fiscal year. Certain program funds were also moved out the bank account used for federal draws and comingled with nonfederal dollars in the University’s operating bank account which resulted in a portion of the funds being used for non-program purposes. Upon identifying this issue, the University subsequent repaid the funds back, however this did not occur in a timely fashion. Cause - Administrative oversight and insufficient internal control. Effect or Potential Effect – Noncompliance with cash management requirements. Questioned Costs – None. Context – For 4 of 6 drawdowns selected for testing, the University was unable to reconcile the amounts drawn with the amounts expended to evidence that the funds were used in a timely manner. Indication of Repeat Finding - No similar findings noted in the prior year. Recommendation – We recommend that the University enhance its internal controls over compliance to ensure that documentation supporting its draws is retained and that time elapsed between transfer and disbursement of federal funds is minimized. We also recommend that the University enhances its internal controls to ensure funds are not comingled with non-program funds to prevent program funds from being used for non-program purposes. Views of Responsible Officials – The University acknowledges that the internal controls surrounding the cash management of the Federal Research and Development Programs was not in compliance for federal standards. The University is in the process of enhancing the internal controls and cash management procedures to prevent this from happening in the future. Going forward all federal grant funds that are allocated for the Challenger Learning Center will go directly into the appropriate bank account and will be drawn down and spent in the correct time frame. When operating expenses are incurred for the Challenger Learning Center the payment will be processed from the University’s general checking and the federal grant funds will reimburse the University that day. The same is also true for the payroll expenses incurred by the Challenger Learning Center. Wages will be paid out of the university’s general checking account and then reimbursed to the university from the bank account that hold the federal grant funds.

Categories

Cash Management Matching / Level of Effort / Earmarking Internal Control / Segregation of Duties

Other Findings in this Audit

  • 399013 2023-013
    Material Weakness
  • 399014 2023-014
    Material Weakness
  • 399015 2023-015
    Significant Deficiency
  • 399016 2023-009
    Significant Deficiency Repeat
  • 399017 2023-010
    Significant Deficiency
  • 399018 2023-016
    Significant Deficiency Repeat
  • 399019 2023-009
    Significant Deficiency Repeat
  • 399020 2023-010
    Significant Deficiency
  • 399021 2023-008
    Material Weakness
  • 399022 2023-010
    Significant Deficiency
  • 399023 2023-004
    -
  • 399024 2023-005
    Material Weakness Repeat
  • 399025 2023-009
    Significant Deficiency Repeat
  • 399026 2023-010
    Significant Deficiency
  • 399027 2023-016
    Significant Deficiency Repeat
  • 399028 2023-005
    Material Weakness Repeat
  • 399029 2023-006
    Material Weakness
  • 399030 2023-007
    Significant Deficiency Repeat
  • 399031 2023-009
    Significant Deficiency Repeat
  • 399032 2023-010
    Significant Deficiency
  • 399033 2023-016
    Significant Deficiency Repeat
  • 399034 2023-009
    Significant Deficiency Repeat
  • 399035 2023-010
    Significant Deficiency
  • 399036 2023-016
    Significant Deficiency Repeat
  • 399037 2023-011
    Significant Deficiency Repeat
  • 399038 2023-012
    Significant Deficiency Repeat
  • 399039 2023-013
    Material Weakness
  • 399040 2023-014
    Material Weakness
  • 975455 2023-013
    Material Weakness
  • 975457 2023-015
    Significant Deficiency
  • 975458 2023-009
    Significant Deficiency Repeat
  • 975459 2023-010
    Significant Deficiency
  • 975460 2023-016
    Significant Deficiency Repeat
  • 975461 2023-009
    Significant Deficiency Repeat
  • 975462 2023-010
    Significant Deficiency
  • 975463 2023-008
    Material Weakness
  • 975464 2023-010
    Significant Deficiency
  • 975465 2023-004
    -
  • 975466 2023-005
    Material Weakness Repeat
  • 975467 2023-009
    Significant Deficiency Repeat
  • 975468 2023-010
    Significant Deficiency
  • 975469 2023-016
    Significant Deficiency Repeat
  • 975470 2023-005
    Material Weakness Repeat
  • 975471 2023-006
    Material Weakness
  • 975472 2023-007
    Significant Deficiency Repeat
  • 975473 2023-009
    Significant Deficiency Repeat
  • 975474 2023-010
    Significant Deficiency
  • 975475 2023-016
    Significant Deficiency Repeat
  • 975476 2023-009
    Significant Deficiency Repeat
  • 975477 2023-010
    Significant Deficiency
  • 975478 2023-016
    Significant Deficiency Repeat
  • 975479 2023-011
    Significant Deficiency Repeat
  • 975480 2023-012
    Significant Deficiency Repeat
  • 975481 2023-013
    Material Weakness
  • 975482 2023-014
    Material Weakness

Programs in Audit

ALN Program Name Expenditures
84.268 Federal Direct Student Loans $6.40M
43.009 Cross Agency Support $2.30M
84.063 Federal Pell Grant Program $867,442
84.425 Education Stabilization Fund $486,600
93.859 Biomedical Research and Research Training $242,923
84.007 Federal Supplemental Educational Opportunity Grants $195,567
84.033 Federal Work-Study Program $75,998
84.379 Teacher Education Assistance for College and Higher Education Grants (teach Grants) $9,430
84.038 Federal Perkins Loan Program $0